DRNA insider trading
Dicerna Pharmaceuticals Inc — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
DRNA insider activity at a glance
FilingIQ has scored 391 insider transactions for DRNA since Jan 9, 2015. The most recent filing in our index is dated Dec 28, 2021.
Across the full history, 8 open-market purchases
and 146 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on DRNA insider trades is 65.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Frequently asked
- How many insider trades does FilingIQ track for DRNA?
- FilingIQ tracks 391 Form 4 insider transactions for DRNA (Dicerna Pharmaceuticals Inc), covering filings from Jan 9, 2015 onwards. 0 of those were filed in the last 90 days.
- Are DRNA insiders net buyers or net sellers?
- Across the full Form 4 history for DRNA, 8 transactions (2%) were open-market purchases and 146 (37%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does DRNA insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
Methodology & sources
Every DRNA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.